Teleflex Incorporated (NYSE:TFX - Free Report) - Investment analysts at Zacks Research lowered their Q4 2024 earnings estimates for Teleflex in a research note issued on Wednesday, January 8th. Zacks Research analyst R. Department now forecasts that the medical technology company will post earnings per share of $3.83 for the quarter, down from their prior estimate of $3.85. The consensus estimate for Teleflex's current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex's Q2 2025 earnings at $3.71 EPS, Q3 2025 earnings at $3.75 EPS, Q4 2025 earnings at $4.18 EPS, FY2025 earnings at $15.16 EPS, Q4 2026 earnings at $4.16 EPS and FY2026 earnings at $16.59 EPS.
TFX has been the topic of several other research reports. Royal Bank of Canada reduced their price target on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. Mizuho reduced their target price on Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a research note on Friday, November 1st. Needham & Company LLC reiterated a "hold" rating on shares of Teleflex in a report on Monday, December 16th. StockNews.com raised Teleflex from a "hold" rating to a "buy" rating in a report on Thursday, November 28th. Finally, Truist Financial decreased their price objective on Teleflex from $227.00 to $200.00 and set a "hold" rating on the stock in a research note on Wednesday, December 18th. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, Teleflex currently has an average rating of "Moderate Buy" and an average target price of $252.50.
Check Out Our Latest Stock Report on Teleflex
Teleflex Price Performance
Shares of Teleflex stock traded down $3.21 on Friday, hitting $174.75. The company's stock had a trading volume of 757,293 shares, compared to its average volume of 475,999. The company has a market capitalization of $8.12 billion, a P/E ratio of 34.74, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. Teleflex has a 52-week low of $171.69 and a 52-week high of $256.85. The firm has a fifty day moving average price of $187.06 and a 200-day moving average price of $216.52. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.
Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.11. The firm had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Teleflex's quarterly revenue was up 2.4% on a year-over-year basis. During the same period last year, the business posted $3.64 EPS.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Cromwell Holdings LLC lifted its stake in shares of Teleflex by 59.0% during the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company's stock worth $33,000 after purchasing an additional 49 shares in the last quarter. Avior Wealth Management LLC boosted its holdings in Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company's stock worth $38,000 after acquiring an additional 101 shares during the period. Ashton Thomas Securities LLC acquired a new stake in Teleflex in the third quarter valued at approximately $40,000. True Wealth Design LLC raised its stake in shares of Teleflex by 16,600.0% during the third quarter. True Wealth Design LLC now owns 167 shares of the medical technology company's stock valued at $41,000 after purchasing an additional 166 shares during the period. Finally, Canada Pension Plan Investment Board acquired a new position in shares of Teleflex during the second quarter worth $42,000. Institutional investors and hedge funds own 95.62% of the company's stock.
Teleflex Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Monday, December 16th. Shareholders of record on Friday, November 15th were paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.78%. The ex-dividend date of this dividend was Friday, November 15th. Teleflex's payout ratio is 27.04%.
About Teleflex
(
Get Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Articles
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
